Protagonist Therapeutics, Inc Investment Income, Interest
Protagonist Therapeutics, Inc (PTGX) reported Investment Income, Interest of $6.43 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2026-08-05
- Protagonist Therapeutics, Inc investment income, interest for the quarter ending 2026-06-30 was $6.43M, a 13.19% decline year-over-year.
- Protagonist Therapeutics, Inc investment income, interest for the quarter ending 2026-03-31 was $5.88M, a 22.41% decline year-over-year.
- Protagonist Therapeutics, Inc investment income, interest for the quarter ending 2025-12-31 was $6.76M, a 1.34% decline year-over-year.
- Protagonist Therapeutics, Inc investment income, interest for the quarter ending 2025-09-30 was $7.05M, a 8.24% decline year-over-year.
- Protagonist Therapeutics, Inc investment income, interest for fiscal 2025 was $28.79M, a 9.40% increase from fiscal 2024.
- Protagonist Therapeutics, Inc investment income, interest for fiscal 2024 was $26.32M, a 76.63% increase from fiscal 2023.
- Protagonist Therapeutics, Inc investment income, interest for fiscal 2023 was $14.90M, a 266.95% increase from fiscal 2022.
- Protagonist Therapeutics, Inc investment income, interest for fiscal 2022 was $4.06M, a 816.48% increase from fiscal 2021.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 3 month as first filed | Investment Income, Interest 6 month | Investment Income, Interest 6 month as first filed | Investment Income, Interest 9 month | Investment Income, Interest 9 month as first filed | Investment Income, Interest 12 month | Investment Income, Interest 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $6.43M 10-Q · filed 2026-08-05 | $12.30M 10-Q · filed 2026-08-05 | $19.07M derived: sum of 3 quarters · filed 2026-08-05 | $26.11M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2026-03-31 | $5.88M 10-Q · filed 2026-05-05 | $12.64M derived: sum of 2 quarters · filed 2026-05-05 | $19.69M derived: sum of 3 quarters · filed 2026-05-05 | $27.09M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-12-31 | $6.76M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $13.81M derived: sum of 2 quarters · filed 2026-02-25 | $21.22M derived: sum of 3 quarters · filed 2026-08-05 | $28.79M 10-K · filed 2026-02-25 | ||||
| 2025-09-30 | $7.05M 10-Q · filed 2025-11-06 | $14.46M derived: sum of 2 quarters · filed 2026-08-05 | $22.03M 10-Q · filed 2025-11-06 | $28.88M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-06-30 | $7.41M 10-Q · filed 2026-08-05 | $14.98M 10-Q · filed 2026-08-05 | $21.83M derived: sum of 3 quarters · filed 2026-08-05 | $29.51M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-03-31 | $7.57M 10-Q · filed 2026-05-05 | $14.43M derived: sum of 2 quarters · filed 2026-05-05 | $22.11M derived: sum of 3 quarters · filed 2026-05-05 | $29.51M derived: sum of 4 quarters · filed 2026-05-05 | ||||
| 2024-12-31 | $6.85M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $14.54M derived: sum of 2 quarters · filed 2026-02-25 | $21.94M derived: sum of 3 quarters · filed 2026-02-25 | $26.32M 10-K · filed 2026-02-25 | ||||
| 2024-09-30 | $7.68M 10-Q · filed 2025-11-06 | $15.09M derived: sum of 2 quarters · filed 2025-11-06 | $19.46M 10-Q · filed 2025-11-06 | $23.70M derived: sum of 4 quarters · filed 2026-02-25 | ||||
| 2024-06-30 | $7.40M 10-Q · filed 2025-08-06 | $11.78M 10-Q · filed 2025-08-06 | $16.02M derived: sum of 3 quarters · filed 2026-02-25 | $20.27M derived: sum of 4 quarters · filed 2026-02-25 | ||||
| 2024-03-31 | $4.38M 10-Q · filed 2025-05-06 | $8.62M derived: sum of 2 quarters · filed 2026-02-25 | $12.87M derived: sum of 3 quarters · filed 2026-02-25 | $16.78M derived: sum of 4 quarters · filed 2026-02-25 | ||||
| 2023-12-31 | $4.24M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $8.49M derived: sum of 2 quarters · filed 2026-02-25 | $12.41M derived: sum of 3 quarters · filed 2026-02-25 | $14.90M 10-K · filed 2026-02-25 | ||||
| 2023-09-30 | $4.25M 10-Q · filed 2024-11-07 | $8.16M derived: sum of 2 quarters · filed 2024-11-07 | $10.66M 10-Q · filed 2024-11-07 | $12.91M derived: sum of 4 quarters · filed 2025-02-21 | ||||
| 2023-06-30 | $3.91M 10-Q · filed 2024-08-06 | $6.40M 10-Q · filed 2024-08-06 | $8.65M derived: sum of 3 quarters · filed 2025-02-21 | $9.81M derived: sum of 4 quarters · filed 2025-02-21 | ||||
| 2023-03-31 | $2.49M 10-Q · filed 2024-05-07 | $4.74M derived: sum of 2 quarters · filed 2025-02-21 | $5.90M derived: sum of 3 quarters · filed 2025-02-21 | $6.38M derived: sum of 4 quarters · filed 2025-02-21 | ||||
| 2022-12-31 | $2.25M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-21 | $3.41M derived: sum of 2 quarters · filed 2025-02-21 | $3.89M derived: sum of 3 quarters · filed 2025-02-21 | $4.06M 10-K · filed 2025-02-21 | ||||
| 2022-09-30 | $1.16M 10-Q · filed 2023-11-02 | $1.64M derived: sum of 2 quarters · filed 2023-11-02 | $1.81M 10-Q · filed 2023-11-02 | $1.93M derived: sum of 4 quarters · filed 2024-02-27 | ||||
| 2022-06-30 | $484.00K 10-Q · filed 2023-08-03 | $652.00K 10-Q · filed 2023-08-03 | $774.00K derived: sum of 3 quarters · filed 2024-02-27 | $896.00K derived: sum of 4 quarters · filed 2024-02-27 | ||||
| 2022-03-31 | $168.00K 10-Q · filed 2023-05-04 | $290.00K derived: sum of 2 quarters · filed 2024-02-27 | $412.00K derived: sum of 3 quarters · filed 2024-02-27 | $509.00K derived: sum of 4 quarters · filed 2024-02-27 | ||||
| 2021-12-31 | $122.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $244.00K derived: sum of 2 quarters · filed 2024-02-27 | $341.00K derived: sum of 3 quarters · filed 2024-02-27 | $443.00K 10-K · filed 2024-02-27 | ||||
| 2021-09-30 | $122.00K 10-Q · filed 2022-11-08 | $219.00K derived: sum of 2 quarters · filed 2022-11-08 | $321.00K 10-Q · filed 2022-11-08 | $401.00K derived: sum of 4 quarters · filed 2023-03-15 | ||||
| 2021-06-30 | $97.00K 10-Q · filed 2022-08-04 | $199.00K 10-Q · filed 2022-08-04 | $279.00K derived: sum of 3 quarters · filed 2023-03-15 | $366.00K derived: sum of 4 quarters · filed 2023-03-15 | ||||
| 2021-03-31 | $102.00K 10-Q · filed 2022-05-05 | $182.00K derived: sum of 2 quarters · filed 2023-03-15 | $269.00K derived: sum of 3 quarters · filed 2023-03-15 | $476.00K derived: sum of 4 quarters · filed 2023-03-15 | ||||
| 2020-12-31 | $80.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | $167.00K derived: sum of 2 quarters · filed 2023-03-15 | $374.00K derived: sum of 3 quarters · filed 2023-03-15 | $900.00K 10-K · filed 2023-03-15 | ||||
| 2020-09-30 | $87.00K 10-Q · filed 2021-11-03 | $294.00K derived: sum of 2 quarters · filed 2021-11-03 | $820.00K 10-Q · filed 2021-11-03 | $1.50M derived: sum of 4 quarters · filed 2022-02-28 | ||||
| 2020-06-30 | $207.00K 10-Q · filed 2021-08-04 | $733.00K 10-Q · filed 2021-08-04 | $1.41M derived: sum of 3 quarters · filed 2022-02-28 | $2.17M derived: sum of 4 quarters · filed 2022-02-28 | ||||
| 2020-03-31 | $526.00K 10-Q · filed 2021-05-04 | $1.21M derived: sum of 2 quarters · filed 2022-02-28 | $1.97M derived: sum of 3 quarters · filed 2022-02-28 | $2.61M derived: sum of 4 quarters · filed 2022-02-28 | ||||
| 2019-12-31 | $679.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $1.44M derived: sum of 2 quarters · filed 2022-02-28 | $2.08M derived: sum of 3 quarters · filed 2022-02-28 | $2.81M 10-K · filed 2022-02-28 | ||||
| 2019-09-30 | $762.00K 10-Q · filed 2020-11-04 | $656.00K 10-Q · filed 2019-11-06 | $1.40M derived: sum of 2 quarters · filed 2020-11-04 | $2.13M 10-Q · filed 2020-11-04 | $1.99M 10-Q · filed 2019-11-06 | $2.90M derived: sum of 4 quarters · filed 2021-03-10 | ||
| 2019-06-30 | $641.00K 10-Q · filed 2020-08-06 | $604.00K 10-Q · filed 2019-08-07 | $1.37M 10-Q · filed 2020-08-06 | $1.33M 10-Q · filed 2019-08-07 | $2.14M derived: sum of 3 quarters · filed 2021-03-10 | $2.79M derived: sum of 4 quarters · filed 2021-03-10 | ||
| 2019-03-31 | $731.00K 10-Q · filed 2020-05-07 | $728.00K 10-Q · filed 2019-05-08 | $1.50M derived: sum of 2 quarters · filed 2021-03-10 | $2.15M derived: sum of 3 quarters · filed 2021-03-10 | $2.73M derived: sum of 4 quarters · filed 2021-03-10 | |||
| 2018-12-31 | $768.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-10 | $1.42M derived: sum of 2 quarters · filed 2021-03-10 | $2.00M derived: sum of 3 quarters · filed 2021-03-10 | $2.57M 10-K · filed 2021-03-10 | $2.55M 10-K · filed 2019-03-12 | |||
| 2018-09-30 | $654.00K 10-Q · filed 2019-11-06 | $1.23M derived: sum of 2 quarters · filed 2019-11-06 | $1.80M 10-Q · filed 2019-11-06 | $2.27M derived: sum of 4 quarters · filed 2020-03-10 | ||||
| 2018-06-30 | $576.00K 10-Q · filed 2019-08-07 | $1.14M 10-Q · filed 2019-08-07 | $1.61M derived: sum of 3 quarters · filed 2020-03-10 | $1.77M derived: sum of 4 quarters · filed 2020-03-10 | ||||
| 2018-03-31 | $568.00K 10-Q · filed 2019-05-08 | $1.04M derived: sum of 2 quarters · filed 2020-03-10 | $1.19M derived: sum of 3 quarters · filed 2020-03-10 | $1.34M derived: sum of 4 quarters · filed 2020-03-10 | ||||
| 2017-12-31 | $469.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-10 | $624.00K derived: sum of 2 quarters · filed 2020-03-10 | $776.00K derived: sum of 3 quarters · filed 2020-03-10 | $948.00K 10-K · filed 2020-03-10 | $940.00K 10-K · filed 2018-03-07 | |||
| 2017-09-30 | $155.00K 10-Q · filed 2018-11-06 | $307.00K derived: sum of 2 quarters · filed 2018-11-06 | $479.00K 10-Q · filed 2018-11-06 | $628.00K derived: sum of 4 quarters · filed 2019-03-12 | ||||
| 2017-06-30 | $152.00K 10-Q · filed 2018-08-07 | $324.00K 10-Q · filed 2018-08-07 | $473.00K derived: sum of 3 quarters · filed 2019-03-12 | $527.00K derived: sum of 4 quarters · filed 2019-03-12 | ||||
| 2017-03-31 | $172.00K 10-Q · filed 2018-05-09 | $321.00K derived: sum of 2 quarters · filed 2019-03-12 | $375.00K derived: sum of 3 quarters · filed 2019-03-12 | $402.00K derived: sum of 4 quarters · filed 2019-03-12 | ||||
| 2016-12-31 | $149.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12 | $203.00K derived: sum of 2 quarters · filed 2019-03-12 | $230.00K derived: sum of 3 quarters · filed 2019-03-12 | $242.00K 10-K · filed 2019-03-12 | ||||
| 2016-09-30 | $54.00K 10-Q · filed 2017-11-07 | $81.00K derived: sum of 2 quarters · filed 2017-11-07 | $93.00K 10-Q · filed 2017-11-07 | $110.00K derived: sum of 4 quarters · filed 2018-03-07 | ||||
| 2016-06-30 | $27.00K 10-Q · filed 2017-08-08 | $39.00K 10-Q · filed 2017-08-08 | $56.00K derived: sum of 3 quarters · filed 2018-03-07 | $57.00K derived: sum of 4 quarters · filed 2018-03-07 | ||||
| 2016-03-31 | $12.00K 10-Q · filed 2017-05-10 | $29.00K derived: sum of 2 quarters · filed 2018-03-07 | $30.00K derived: sum of 3 quarters · filed 2018-03-07 | |||||
| 2015-12-31 | $17.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-07 | $18.00K derived: sum of 2 quarters · filed 2018-03-07 | $19.00K 10-K · filed 2018-03-07 | |||||
| 2015-09-30 | $1.00K 10-Q · filed 2016-11-14 | $2.00K 10-Q · filed 2016-11-14 | ||||||
| 2015-06-30 | $1.00K 10-Q · filed 2016-09-15 | |||||||
| 2014-12-31 | $16.00K 10-K · filed 2017-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |